Manila Times Business
Autolus Therapeutics Receives Prix Galien UK Award
LONDON and GAITHERSBURG, Md., June 12, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Galien Foundation has presented the Company with the 2026 Prix Galien UK Award for Best Biotechnology Product. Winners of the prestigious Prix Galien awards are selected by a UK Awards Committee, which comprises 12 experts i
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Ateneo warns public to exercise discernment amid fake statement
2h ago
DepEd completes nationwide orientations on Learning Systems Policy Reforms
2h ago
DYWIDAG Group - DSI Holding GmbH has successfully priced a subsequent bond issuance and initiates written procedure under its existing bonds
2h ago
DYWIDAG Group Acquisition of Interspan
2h ago